Inventory Summary of Amedisys, Inc.

Amedisys, Inc.'s latest annual inventory in 2023 was - USD , down -100.0% from previous year.
Amedisys, Inc.'s latest quarterly inventory in 2024 Q2 was - USD , down 0.0% from previous quarter.
Amedisys, Inc. reported annual inventory of 25.22 Million USD in 2022, up 87.78% from previous year.
Amedisys, Inc. reported annual inventory of 13.43 Million USD in 2021, up 14.15% from previous year.
Amedisys, Inc. reported quarterly inventory of - USD for 2024 Q1, down 0.0% from previous quarter.
Amedisys, Inc. reported quarterly inventory of 38.41 Million USD for 2023 Q1, up 52.33% from previous quarter.

Annual Inventory Chart of Amedisys, Inc. (2023 - 1993)

Historical Annual Inventory of Amedisys, Inc. (2023 - 1993)

Year	Inventory	Inventory Growth
2023	- USD	-100.0%
2022	25.22 Million USD	87.78%
2021	13.43 Million USD	14.15%
2020	11.76 Million USD	-84.19%
2019	74.43 Million USD	883.6%
2018	7.56 Million USD	3.26%
2017	7.32 Million USD	-0.92%
2016	7.39 Million USD	-8.79%
2015	8.11 Million USD	-4.51%
2014	8.49 Million USD	-87.14%
2013	66.05 Million USD	521.37%
2012	10.63 Million USD	-6.09%
2011	11.32 Million USD	13.81%
2010	9.94 Million USD	-3.23%
2009	10.27 Million USD	27.12%
2008	8.08 Million USD	34.25%
2007	6.02 Million USD	-32.55%
2006	8.93 Million USD	0.0%
2005	- USD	-100.0%
2004	3.37 Million USD	79.72%
2003	1.87 Million USD	119.25%
2002	857 Thousand USD	4.26%
2001	822 Thousand USD	98.55%
2000	414 Thousand USD	-14.99%
1999	487 Thousand USD	-71.4%
1998	1.7 Million USD	217.72%
1997	536 Thousand USD	21.24%
1996	442.1 Thousand USD	121.05%
1995	200 Thousand USD	100.0%
1994	100 Thousand USD	0.0%
1993	100 Thousand USD	0.0%

Year	Inventory	Inventory Growth
2024 Q2	- USD	0.0%
2024 Q1	- USD	0.0%
2023 Q1	38.41 Million USD	52.33%
2023 Q3	36.43 Million USD	23.28%
2023 Q2	29.55 Million USD	-23.06%
2023 Q4	- USD	-100.0%
2023 FY	- USD	-100.0%
2022 Q3	30.51 Million USD	-18.4%
2022 FY	25.22 Million USD	87.78%
2022 Q1	20.29 Million USD	51.11%
2022 Q2	37.39 Million USD	84.26%
2022 Q4	25.22 Million USD	-17.35%
2021 Q2	12.97 Million USD	-21.1%
2021 Q3	19.83 Million USD	52.79%
2021 FY	13.43 Million USD	14.15%
2021 Q1	16.44 Million USD	39.8%
2021 Q4	13.43 Million USD	-32.27%
2020 Q2	13.83 Million USD	-10.98%
2020 Q4	11.76 Million USD	-32.59%
2020 Q3	17.45 Million USD	26.15%
2020 Q1	15.54 Million USD	-79.12%
2020 FY	11.76 Million USD	-84.19%
2019 Q1	10.79 Million USD	42.6%
2019 FY	74.43 Million USD	883.6%
2019 Q4	74.43 Million USD	602.19%
2019 Q2	8.95 Million USD	-17.0%
2019 Q3	10.6 Million USD	18.35%
2018 Q2	10.49 Million USD	-15.58%
2018 Q3	11.67 Million USD	11.3%
2018 Q4	7.56 Million USD	-35.2%
2018 Q1	12.43 Million USD	69.6%
2018 FY	7.56 Million USD	3.26%
2017 Q2	8.8 Million USD	-12.85%
2017 Q3	9.77 Million USD	11.02%
2017 Q4	7.32 Million USD	-24.98%
2017 Q1	10.09 Million USD	36.5%
2017 FY	7.32 Million USD	-0.92%
2016 FY	7.39 Million USD	-8.79%
2016 Q3	9.94 Million USD	25.43%
2016 Q4	7.39 Million USD	-25.64%
2016 Q1	9.08 Million USD	12.03%
2016 Q2	7.93 Million USD	-12.71%
2015 Q2	7.56 Million USD	-11.01%
2015 Q1	8.5 Million USD	0.13%
2015 FY	8.11 Million USD	-4.51%
2015 Q4	8.11 Million USD	-74.66%
2015 Q3	32 Million USD	322.9%
2014 Q2	21.56 Million USD	-69.63%
2014 Q4	8.49 Million USD	-60.42%
2014 FY	8.49 Million USD	-87.14%
2014 Q1	71.01 Million USD	7.51%
2014 Q3	21.45 Million USD	-0.51%
2013 Q3	69.81 Million USD	367.97%
2013 FY	66.05 Million USD	521.37%
2013 Q2	14.91 Million USD	3.05%
2013 Q4	66.05 Million USD	-5.38%
2013 Q1	14.47 Million USD	36.19%
2012 Q4	10.63 Million USD	-0.14%
2012 Q1	12.76 Million USD	12.76%
2012 Q2	11.18 Million USD	-12.42%
2012 Q3	10.64 Million USD	-4.78%
2012 FY	10.63 Million USD	-6.09%
2011 Q1	11.6 Million USD	16.67%
2011 FY	11.32 Million USD	13.81%
2011 Q2	10.97 Million USD	-5.42%
2011 Q3	10.95 Million USD	-0.24%
2011 Q4	11.32 Million USD	3.39%
2010 FY	9.94 Million USD	-3.23%
2010 Q1	12.65 Million USD	23.08%
2010 Q2	11.71 Million USD	-7.41%
2010 Q4	9.94 Million USD	107.29%
2010 Q3	-136.45 Million USD	-1264.94%
2009 Q2	8.86 Million USD	-12.47%
2009 Q4	10.27 Million USD	11.74%
2009 Q3	9.19 Million USD	3.77%
2009 Q1	10.12 Million USD	25.25%
2009 FY	10.27 Million USD	27.12%
2008 FY	8.08 Million USD	34.25%
2008 Q1	10.71 Million USD	77.88%
2008 Q2	9.64 Million USD	-9.96%
2008 Q3	7.15 Million USD	-25.79%
2008 Q4	8.08 Million USD	12.95%
2007 Q2	10.69 Million USD	-2.84%
2007 FY	6.02 Million USD	-32.55%
2007 Q3	10.88 Million USD	1.78%
2007 Q1	11.01 Million USD	23.31%
2007 Q4	6.02 Million USD	-44.69%
2006 Q1	4.9 Million USD	0.0%
2006 FY	8.93 Million USD	0.0%
2006 Q2	4.28 Million USD	-12.64%
2006 Q3	3.22 Million USD	-24.83%
2006 Q4	8.93 Million USD	177.16%
2005 Q3	5.82 Million USD	80.4%
2005 FY	- USD	-100.0%
2005 Q4	- USD	-100.0%
2005 Q2	3.23 Million USD	13.81%
2005 Q1	2.83 Million USD	-15.96%
2004 Q1	1.26 Million USD	-32.46%
2004 FY	3.37 Million USD	79.72%
2004 Q4	3.37 Million USD	172.78%
2004 Q3	1.23 Million USD	10.24%
2004 Q2	1.12 Million USD	-11.51%
2003 Q2	722 Thousand USD	-33.88%
2003 Q1	1.09 Million USD	27.42%
2003 Q4	1.87 Million USD	96.75%
2003 FY	1.87 Million USD	119.25%
2003 Q3	955 Thousand USD	32.27%
2002 Q4	857 Thousand USD	-8.93%
2002 Q2	1.01 Million USD	-16.54%
2002 Q1	1.21 Million USD	47.81%
2002 FY	857 Thousand USD	4.26%
2002 Q3	941 Thousand USD	-7.2%
2001 Q3	929 Thousand USD	-16.53%
2001 FY	822 Thousand USD	98.55%
2001 Q2	1.11 Million USD	31.56%
2001 Q1	846 Thousand USD	104.35%
2001 Q4	822 Thousand USD	-11.52%
2000 FY	414 Thousand USD	-14.99%
2000 Q2	712 Thousand USD	26.92%
2000 Q4	414 Thousand USD	20.7%
2000 Q3	343 Thousand USD	-51.83%
2000 Q1	561 Thousand USD	12.2%
1999 Q1	1.3 Million USD	-23.66%
1999 Q4	500 Thousand USD	-66.67%
1999 Q3	1.5 Million USD	7.14%
1999 FY	487 Thousand USD	-71.4%
1999 Q2	1.4 Million USD	7.69%
1998 FY	1.7 Million USD	217.72%
1998 Q3	- USD	0.0%
1998 Q4	1.7 Million USD	0.0%
1998 Q1	- USD	-100.0%
1998 Q2	- USD	0.0%
1997 Q3	- USD	0.0%
1997 Q2	- USD	0.0%
1997 FY	536 Thousand USD	21.24%
1997 Q1	- USD	-100.0%
1997 Q4	536 Thousand USD	0.0%
1996 Q2	- USD	0.0%
1996 Q3	- USD	0.0%
1996 FY	442.1 Thousand USD	121.05%
1996 Q1	- USD	-100.0%
1996 Q4	442.1 Thousand USD	0.0%
1995 FY	200 Thousand USD	100.0%
1995 Q2	- USD	0.0%
1995 Q1	- USD	-100.0%
1995 Q3	- USD	0.0%
1995 Q4	200 Thousand USD	0.0%
1994 FY	100 Thousand USD	0.0%
1994 Q4	100 Thousand USD	0.0%
1994 Q2	- USD	0.0%
1994 Q1	- USD	-100.0%
1993 FY	100 Thousand USD	0.0%
1993 Q4	100 Thousand USD	0.0%

Peer Inventory Comparison of Amedisys, Inc.

Name	Inventory	Inventory Difference
Acadia Healthcare Company, Inc.	5.3 Million USD	100.0%
Addus HomeCare Corporation	- USD	NaN%
AirSculpt Technologies, Inc.	- USD	NaN%
American Oncology Network, Inc.	44.56 Million USD	100.0%
Astrana Health, Inc.	- USD	NaN%
Aveanna Healthcare Holdings Inc.	- USD	NaN%
IMAC Holdings, Inc.	- USD	NaN%
biote Corp.	20.94 Million USD	100.0%
Cryo-Cell International, Inc.	768.87 Thousand USD	100.0%
Cross Country Healthcare, Inc.	- USD	NaN%
COMPASS Pathways plc	1.00 USD	100.0%
DocGo Inc.	1.00 USD	100.0%
The Ensign Group, Inc.	- USD	NaN%
Healthcare Services Group, Inc.	18.47 Million USD	100.0%
InnovAge Holding Corp.	-3.32 Million USD	100.0%
Assure Holdings Corp.	1.00 USD	100.0%
The Joint Corp.	- USD	NaN%
LifeStance Health Group, Inc.	1.00 USD	100.0%
Mobile-health Network Solutions Class A Ordinary Shares	163.99 Thousand USD	100.0%
ModivCare Inc.	- USD	NaN%
NewGenIvf Group Limited	126.26 Thousand USD	100.0%
Novo Integrated Sciences, Inc.	1.1 Million USD	100.0%
Option Care Health, Inc.	274 Million USD	100.0%
P3 Health Partners Inc.	- USD	NaN%
P3 Health Partners Inc.	- USD	NaN%
The Pennant Group, Inc.	- USD	NaN%
Surgery Partners, Inc.	75.2 Million USD	100.0%
Syra Health Corp. Class A Common Stock	1.00 USD	100.0%
Talkspace, Inc.	- USD	NaN%
Talkspace, Inc.	- USD	NaN%
The Oncology Institute, Inc.	13.67 Million USD	100.0%
The Oncology Institute, Inc.	13.67 Million USD	100.0%

Global Stocks Search

Amedisys, Inc. (AMED)

Inventory Summary of Amedisys, Inc.

Annual Inventory Chart of Amedisys, Inc. (2023 - 1993)

Historical Annual Inventory of Amedisys, Inc. (2023 - 1993)

Peer Inventory Comparison of Amedisys, Inc.